Xenon Pharmaceuticals (NASDAQ:XENE) Issues Quarterly Earnings Results, Misses Expectations By $0.01 EPS
Xenon Pharmaceuticals (NASDAQ:XENE – Get Rating) announced its quarterly earnings results on Tuesday. The biopharmaceutical company reported ($0.63) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.62) by ($0.01), Briefing.com reports. Xenon Pharmaceuticals had a negative net margin of 862.06% and a negative return on equity of 17.90%. During the same […]